Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group.

C, Ganzel; S, Trestman; S, Levi; ME, Gatt; N, Lavi; I, Vaxman; O, Rouvio; H, Magen; E, Lebel; NA, Horowitz; M, Leiba; T, Tadmor; Tzarfati K, Herzog; C, Surio; S, Yeganeh; N, Dally; I, Avivi; YC, Cohen

doi:10.1080/10428194.2022.2118535

Public

Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group.

Shared by NobleBlocks on Sep 8, 2022 • 12:00 AM UTC

Authors:

Ganzel C

Trestman S

Levi S

Abstract

Solitary plasmacytoma (SP) is a rare plasma cell dyscrasia. In this retrospective multicenter study, 68 SP patients were included. Compared to solitary extramedullary plasmacytoma (SEP), patients with solitary bone plasmacytoma (SBP) were younger (57.3 vs. 70.9 years, p = 0.031), had larger plasmacy...

Subject

Multiple myeloma

Radiotherapy

Solitary Plasmacytoma

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!